Sep 14, 2026, 10:46 PM
The AZCERT Scientific Review Committee has found that two newly marketed drugs - Vepdegestrand (anti-cancer drug) and Zidesamtinib (anti-cancer drug) - are associated with QT prolongation but lack convincing evidence of causing torsades de pointes (TdP).
Print
Share
RSS
Donate